With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a ...

The US Therapeutic Plasma Exchange Market represents a critical segment within the broader apheresis and blood purification ...

Press Release  Medical technology leader, Medtronic has successfully concluded the UK leg of its European ACM2U Truck ...

Julie Dehaene-Puype joins Kyowa Kirin as new President of the International RegionJeremy Morgan will retire at the end of December 2025 after a two-month leadership transition periodGalashiels and ...

The Voorhees clinic, located at 1006 Kresson Road near Centennial Blvd, will host a ribbon cutting on November 6 at 2 p.m. in partnership with the Southern New Jersey Chamber of Commerce. VOORHEES, ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Vicore Pharma Holding AB (STO: ...

Imperial Brands has carried out two new behavioural studies[1] into its vape product, blu, showing how adult smokers use it in their daily lives to reduce – or even replace – cigarettes.Our scientists ...

Today, the biopharmaceutical group Chiesi, a major player in the treatment of respiratory diseases, inaugurated the expansion of its industrial site located in La Chaussée-Saint-Victor, near Blois, in ...

DENVER, CO / ACCESS Newswire / November 4, 2025 / ForCast Orthopedics, a development-stage company focused on modernizing care for complex orthopedic infections, today announced that the US Food and ...

Faith Recovery, a Williamsburg-based drug recovery program, recently earned a three-year accreditation from the Commission on ...

SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.

Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused ...